Hepatic Encephalopathy: all 225 studies
Page 3 of 3. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.CompletedNCT01041755Phase 4
- Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of LifeCompletedNCT01008293Phase 2/3
- Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic EncephalopathyCompletedNCT00992290Phase 1
- A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control GroupCompletedNCT00986895Phase 1
- A Multi-Center Group to Study Acute Liver Failure in ChildrenCompletedNCT00986648
- Effects of Proteins in Patients With Cirrhosis and Prior Hepatic EncephalopathyCompletedNCT00955500Phase 4
- Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy SubjectsCompletedNCT00931060Not applicable
- A Study of Controlled Lactulose WithdrawalCompletedNCT00914056Not applicable
- Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal EncephalopathyStatus unknownNCT00896831Phase 4
- Efficacy of Albumin for Acute Encephalopathy in Patients With CirrhosisCompletedNCT00886925Phase 4
- AST-120 Used to Treat Mild Hepatic EncephalopathyCompletedNCT00867698Phase 2
- Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver TransplantationCompletedNCT00839358Phase 4
- Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic EncephalopathyCompletedNCT00740142Phase 4
- The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver FailureCompletedNCT00655304Not applicable
- Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic EncephalopathyCompletedNCT00558038Phase 2
- Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal HemorrhageStatus unknownNCT00553423Phase 3
- Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic EncephalopathyCompletedNCT00433368Phase 3
- Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous SystemCompletedNCT00424957
- Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered StentsTerminatedNCT00401895Phase 2
- Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of LifeCompletedNCT00375375Phase 4
- Probiotics for the Prevention of Major Complications of CirrhosisCompletedNCT00312910Not applicable
- Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.CompletedNCT00305591Not applicable
- Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)CompletedNCT00287235Not applicable
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic EncephalopathyStatus unknownNCT00281502Phase 2
- Phase II Study of Lactulose and Circadian Rhythms in Patients With CirrhosisCompletedNCT00004796Phase 2